A Prospective Pharmacodynamic Study of Rivaroxaban Using Peak and Trough Coagulation Test Results in Patients on Therapeutic Doses of Rivaroxaban
Phase of Trial: Phase II
Latest Information Update: 01 Aug 2015
At a glance
- Drugs Rivaroxaban (Primary)
- Indications Thrombosis
- Focus Pharmacodynamics
- 01 Aug 2015 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 18 Jun 2013 Planned End Date changed from 1 Feb 2013 to 1 Aug 2013 as reported by ClinicalTrials.gov.
- 18 Jun 2013 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.